Sanofi announced on October 27 that it plans to spin off its consumer healthcare business by creating a listed entity headquartered in France, as early as the fourth quarter of 2024.

Pharmaceutical R&D Developer
Sanofi announced on October 27 that it plans to spin off its consumer healthcare business by creating a listed entity headquartered in France, as early as the fourth quarter of 2024.